Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Endothelial Antibody Factory" at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases.
Thinard R, Farkas AE, Halasa M, Chevalier M, Brodaczewska K, Majewska A, Zdanowski R, Paprocka M, Rossowska J, Duc LT, Greferath R, Krizbai I, Van Leuven F, Kieda C, Nicolau C. Thinard R, et al. Among authors: halasa m. Pharmaceutics. 2022 Jul 6;14(7):1418. doi: 10.3390/pharmaceutics14071418. Pharmaceutics. 2022. PMID: 35890313 Free PMC article.
Molecular tracking of interactions between progenitor and endothelial cells via Raman and FTIR spectroscopy imaging: a proof of concept of a new analytical strategy for in vitro research.
Augustyniak K, Pragnaca A, Lesniak M, Halasa M, Borkowska A, Pieta E, Kwiatek WM, Kieda C, Zdanowski R, Malek K. Augustyniak K, et al. Among authors: halasa m. Cell Mol Life Sci. 2023 Oct 18;80(11):329. doi: 10.1007/s00018-023-04986-3. Cell Mol Life Sci. 2023. PMID: 37851174 Free PMC article.
Correction: Molecular tracking of interactions between progenitor and endothelial cells via Raman and FTIR spectroscopy imaging: a proof of concept of a new analytical strategy for in vitro research.
Augustyniak K, Pragnaca A, Lesniak M, Halasa M, Borkowska A, Pieta E, Kwiatek WM, Kieda C, Zdanowski R, Malek K. Augustyniak K, et al. Among authors: halasa m. Cell Mol Life Sci. 2024 Jan 28;81(1):66. doi: 10.1007/s00018-023-05038-6. Cell Mol Life Sci. 2024. PMID: 38281201 Free PMC article. No abstract available.
Valproic Acid and Breast Cancer: State of the Art in 2021.
Wawruszak A, Halasa M, Okon E, Kukula-Koch W, Stepulak A. Wawruszak A, et al. Among authors: halasa m. Cancers (Basel). 2021 Jul 7;13(14):3409. doi: 10.3390/cancers13143409. Cancers (Basel). 2021. PMID: 34298623 Free PMC article. Review.
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells.
Wawruszak A, Kalafut J, Okon E, Czapinski J, Halasa M, Przybyszewska A, Miziak P, Okla K, Rivero-Muller A, Stepulak A. Wawruszak A, et al. Among authors: halasa m. Cancers (Basel). 2019 Jan 27;11(2):148. doi: 10.3390/cancers11020148. Cancers (Basel). 2019. PMID: 30691229 Free PMC article. Review.
Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.
Wawruszak A, Luszczki JJ, Kalafut J, Okla K, Halasa M, Rivero-Muller A, Stepulak A. Wawruszak A, et al. Among authors: halasa m. Int J Mol Sci. 2019 Jul 26;20(15):3663. doi: 10.3390/ijms20153663. Int J Mol Sci. 2019. PMID: 31357442 Free PMC article.
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties.
Wawruszak A, Gumbarewicz E, Okon E, Jeleniewicz W, Czapinski J, Halasa M, Okla K, Smok-Kalwat J, Bocian A, Rivero-Muller A, Stepulak A. Wawruszak A, et al. Among authors: halasa m. Cancer Manag Res. 2019 Sep 13;11:8345-8358. doi: 10.2147/CMAR.S210029. eCollection 2019. Cancer Manag Res. 2019. PMID: 31571991 Free PMC article.
65 results